| Company/Division name | Regeneron Pharmaceuticals |
| Type of work | Manufacturing |
| Reshoring category: | Kept from Offshoring |
| Total number of jobs (added or to be added): | 1500 |
| Year reshoring announced: | 2018 |
| Year reshoring implemented or to be implemented: | 2025 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 800 |
| Country(ies) from which reshored: | Ireland |
| City reshored to: | East Greenbush |
| State(s) reshored to: | NY |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Government Incentives |
| Government Incentive dollar amount: | 140000000 |
